Table 1 Each parameter of the 18 patients who fulfilled the inclusion criteria
Table 1 Each parameter of the 18 patients who fulfilled the inclusion criteria
author: Keisuke Yasuda,Shinsuke Okada,Yohei Okazaki,Kyou Hiasa,Kazuhiro Tsuga, Yasuhiko Abe | publisher: drg. Andreas Tjandra, Sp. Perio, FISID
Case no. | Gender | Age [years] | Bone turnover marker | Position | Implant | Bone Density [HU] | Follow-up period [m] | Marginal bone loss [mm] | |||
---|---|---|---|---|---|---|---|---|---|---|---|
OC | BAP | ICTP | NTX | ||||||||
1 | M | 60.2 | 5.8 | 8.1 | 2.7 | 11.4 | 7┐ | SLA | 1112.63 | 10 | - |
6┐ | SLA | 815.75 | 10 | - | |||||||
2 | M | 51.3 | 4.9 | 9.9 | 3.0 | 12.0 | 6┐ | SLA | 746.00 | 6 | 0.32 |
5┐ | SLA | 893.55 | 6 | 0.12 | |||||||
┌5 | SLA | 861.52 | 19 | 0.13 | |||||||
┌6 | SLA | 549.77 | 19 | 0.00 | |||||||
┌7 | SLA | 415.24 | 19 | 0.07 | |||||||
3 | M | 64.3 | 3.5 | 8.7 | 2.4 | 12.9 | ┌6 | SLA | 593.45 | 36 | 0.39 |
4 | M | 54.0 | 4.8 | 11.6 | 2.6 | - | ┌7 | SLA | 2001.55 | 19 | - |
5 | M | 60.8 | 5.2 | 13.3 | 2.8 | 9.8 | 7┐ | Mk-III | 530.18 | 24 | 0.26 |
6┐ | Mk-III | 853.68 | 24 | 0.40 | |||||||
5┐ | Mk-III | 951.56 | 24 | 0.27 | |||||||
┌6 | Mk-III | 563.19 | 24 | 0.88 | |||||||
┌7 | Mk-III | 595.82 | 24 | 0.80 | |||||||
6 | F | 58.1 | 8.8 | 14.2 | 2.2 | 14.0 | 4┐ | Mk-III | 1138.26 | 21 | 1.14 |
6┐ | Mk-III | 1012.40 | 21 | 1.09 | |||||||
7 | M | 53.4 | 3.3 | 13.3 | 3.0 | 15.4 | 7┐ | Mk-III | 1070.54 | 48 | 0.33 |
6┐ | Mk-III | 1213.59 | 48 | 0.58 | |||||||
8 | F | 51.2 | 4.2 | 11.6 | 2.7 | 10.4 | 7┐ | Mk-III | 898.31 | 20 | 0.61 |
6┐ | Mk-III | 782.95 | 20 | 0.94 | |||||||
9 | M | 62.5 | 5.2 | 13.1 | 2.4 | 12.8 | 5┐ | Mk-III | 761.43 | 6 | 0.18 |
10 | F | 54.3 | 11.0 | 23.0 ↑ | 3.0 | 18.2 ↑ | ┌6 | SLA | 400.65 | 17 | 0.11 |
┌7 | SLA | 333.05 | 17 | 0.03 | |||||||
11 | F | 60.3 | 14.9 ↑ | 21.1 ↑ | 3.9 | 12.6 | ┌6 | SLA | 405.96 | 12 | 0.20 |
┌7 | SLA | 15.77 | 12 | 0.36 | |||||||
12 | F | 67.8 | 4.8 | 19.4 ↑ | 3.6 | 12.3 | ┌4 | SLA | 1112.42 | 23 | 0.39 |
13 | F | 75.5 | 4.1 | 26.5 ↑ | 3.6 | 16.3 | ┌6 | SLA | 395.40 | 48 | 0.03 |
14 | F | 58.8 | 7.8 | 16.9 ↑ | 3.1 | 18.0 ↑ | 7┐ | SLA | 396.18 | 8 | 0.16 |
5┐ | SLA | 502.17 | 8 | 0.02 | |||||||
15 | F | 60.6 | 6.1 | 22.2 ↑ | 2.9 | 11.3 | 6┐ | Mk-III | 314.49 | 24 | 0.32 |
16 | F | 64.5 | 9.4 | 15.4 ↑ | 3.5 | 21.1 ↑ | 4┐ | Mk-III | 620.43 | 29 | 0.80 |
17 | F | 63.3 | 8.1 | 17.5 ↑ | 3.0 | 15.5 | ┌6 | Mk-III | 734.52 | 30 | 1.07 |
┌7 | Mk-III | 624.92 | 30 | 0.99 | |||||||
18 | F | 63.1 | 7.8 | 15.4 ↑ | 3.3 | 22.2 ↑ | 6┐ | Mk-III | 812.32 | 21 | 0.94 |
5┐ | Mk-III | 644.81 | 21 | 1.11 |
Serial posts:
- Bone turnover markers to assess jawbone quality prior to dental implant treatment: a case-control study
- Background : Bone turnover markers to assess jawbone quality prior to dental implant treatment
- Background : Bone turnover markers to assess jawbone quality prior to dental implant treatment (1)
- Background : Bone turnover markers to assess jawbone quality prior to dental implant treatment (2)
- Materials and methods : Bone turnover markers to assess jawbone quality prior to dental implant treatment (1)
- Results : Bone turnover markers to assess jawbone quality prior to dental implant treatment (2)
- Discussion : Bone turnover markers to assess jawbone quality prior to dental implant treatment (1)
- Discussion : Bone turnover markers to assess jawbone quality prior to dental implant treatment (2)
- Discussion : Bone turnover markers to assess jawbone quality prior to dental implant treatment (3)
- Figure 1. Measure the bone density at the implant placement sites
- Figure 2. Measurement of marginal bone loss (MBL) on dental radiography.
- Table 1 Each parameter of the 18 patients who fulfilled the inclusion criteria
- Table 2 Age, sex, and follow-up period between the normal and abnormal group
- Figure 3. The overview on BTM values are shown
- Figure 4. Cancellous bone densities in the normal and abnormal groups of women
- Figure 5. Cancellous bone densities in SLA and MK-III implants
- Figure 6. Marginal bone loss (MBL) in SLA and MK-III implants